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A B S T R A C T
Lichen planus (LP) is a common mucocutaneous disease of unknown aetiology with various geographical prevalence,
may be related to some serious disorders such as squamous cell carcinoma and often remains underdiagnosed. The aim
of this retrospective study was to thoroughly determine localization and clinical characteristics of LP lesions in a cohort
of 173 Slovenian patients in association to the presence of accompanying symptoms and history of potential stressful
events. Isolated cutaneous lesions of LP were found in 56.6% and isolated oral LP in 3.5% of patients. Thirty-four per-
cent presented orocutaneous LP, whereas genitocutaneous LP was noted in 1.2%, orogenito-cutaneous LP in 4% and
orogenital LP in 0.5% of patients. Underlying stressful events were noted in 36 out of 137 (26.3%) patients. Despite obvi-
ously visible localization of the lesions various medical specialists should be familiar with LP and thoroughly examine
the complete skin, as well as oral, genital and anal mucosa in each LP patient to avoid a delay in diagnosing this disease
and possibly disclose a much serious underlying condition. Psychological support should be offered, if needed.
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Introduction
Lichen planus (LP) is a common skin disease, affect-
ing 1 to 2% of the population1. Its incidence is equal to or
even greater compared to diseases such as psoriasis2. It is
a chronic inflammatory dermatosis. Infectious (e.g. hepa-
titis C virus), autoimmune, metabolic, genetic or psycho-
somatic factors have been proposed to be involved in its
aetiology3–5. Herpes simplex virus 1 DNA was occasion-
ally found in erosive form of OLP6. Stressful events are
closely related with this disease7,8. The role of dental ma-
terials in development of oral LP (OLP) is unclear, but
interactions of different dental alloys (polymetalism) as
amalgam and various prosthetic alloys could have a neg-
ative effect on oral mucosa, resulting as OLP9.
Lichen planus is clinically and histologically typical,
usually pruritic papular disease which can affect skin
and mucosa on various body regions (oral cavity, anoge-
nital region, oesophagus, etc.) (Figures 1 and 2). Lesions
of LP may be described using the six »P«: pruritic, polyg-
onal, plane, purple papules and plaques. Predominant
locations of skin involvement are flexure surfaces of
wrists, anterior surface of the lower limbs and lumbar re-
gion. While some patients may be asymptomatic, most
experience intense pruritus. Lichen planus may also in-
volve the nails, which produces thinning and ridging of
nail plate and splitting of distant free edge of nail. Hea-
ling with a scar may produce a pterygium. Scalp LP pres-
ents with areas of hair loss with keratotic follicular
papules and, if left untreated, these areas progress to
scarring alopecia and re-growth of hair will not occur.
Two types of OLP have been described: reticular and ero-
sive with buccal, tongue and gingival mucosa being pre-
dominantly affected. Skin lesions may be disfiguring and
involvement of the oral, genital or anal mucosa may be
debilitating in severe cases. Erosive oral or anogenital
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LP may be very painful. Long-standing cases may lead to
alterations of the genital architecture10 and squamous
cell carcinoma (SCC) has been reported in patients with
genital and anal LP11–13. Neoplastic transformation of
hypertrophic LP on extremities has also been reported14,
as well as SCC developing within oral cavity6. Therefore,
follow-up and biopsy of any suspicious lesions are neces-
sary. Moreover, the diagnosis of LP may disclose some
other life threatening underlying diseases like chronic
hepatitis C.
The only differential diagnosis to be considered in a
typical case of LP is that of lichenoid eruptions induced
by drugs (antihypertensives, nonsteroidal anti-inflam-
matory drugs, etc.) or colour developer, both based on the
history of triggering agents15. Less typical cases of LP
may be mistaken for plane warts, eczematous eruptions
with lichenification from scratching, pityriasis rosea or
lichen simplex chronicus16. The occasional cases of LP
without itching must be distinguished from secondary
syphilis as well. Some cases of LP may clear spontane-
ously in a few weeks, but most acute and subacute at-
tacks may last from six to nine months unless treated
with potent topical or systemic corticosteroids15.
The aim of our study was to determine the localiza-
tion and clinical characteristics of LP lesions in a cohort
of Slovenian patients and find out a possible association
to some chosen variables including stressful events as-
suming that the thorough evaluation of the skin and all
the reachable mucosa is obligatory.
Methods
We retrospectively studied medical records of all the
patients treated for LP at the Department of Dermatove-
nereology, University Medical Centre, Ljubljana, Slove-
nia in the period from January 2001 to January 2006.
Data from patients’ medical records used for analysis
were retrieved by one research dermatologist at a single
point in time. They comprised basic clinical evaluation of
LP patients which was performed by the personal derma-
tologist of each patient; occasionally patients with muco-
sal LP were examined by either proctologist, gynecolo-
gist or dentist, as well. The analyzed medical records
were evaluated for localization of the lesions, the pres-
ence of accompanying symptoms and history of possible
stressful events prior to LP appearance. Stressful events
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Fig. 1. Cutaneous lichen planus of a 54-year old female patient.
a) Forearm b) Hand.
Fig. 2. Oral lichen planus in a 46-year old male patient.
a) Tongue b) Hard palate.
were categorized into three groups: underlying disease,
job related problems and family matters. The patients
suspected of drug-induced lichenoid eruptions were not
included. The diagnosis of LP was primarily made clini-
cally by a typical skin and/or mucosal manifestation and,
in case of severe, long-lasting, neoplastic suspicious le-
sions histopathologic confirmation was performed. Li-
chen planus was classified clinically as mucosal (oral,
genital, anal), cutaneous and mucocutaneous. In case of
missing data the patients were re-invited to the Depart-
ment for completion of the records (thorough dermato-
logical examination, history of possible stressful events).
The c2-test and independent samples t-test were used
for group comparison, calculated with the Systat 5.0 sta-
tistical package. Statistical significance was set at the
p<0.05.
The study was approved by the Ethics Committee of
the Ministry of Health of Republic of Slovenia.
Results
There were all together 173 patients included, 108 fe-
males (62.4%) and 65 males (37.6%), mean age was
50±14.1 years (Table 1). Male to female ratio was 1:1.6.
The female patients with LP were significantly older
than the male patients (p=0.005). Ninety-seven patients
(56.1%) fell in the age group of 41 to 60 years (Figure 3).
The youngest patient was a boy of 12 years, and the old-
est patient was a 86-year-old female. As shown in Table 1
isolated cutaneous manifestations were present in 98 pa-
tients (56.6%), isolated mucosal lesions in 7 patients
(4.1%) and a combination of mucosal and cutaneous le-
sions were observed in 68 (39.3%). Upper limbs were
most commonly involved (80.3%), followed by lower limbs
(76.9%) and trunk (48.0%) as seen in Figure 4. None of
the patients had a face or scalp involvement. Fifty-nine
patients (34.1%) presented orocutaneous lesions, two pa-
tients (1.2%) had genitocutaneous involvement and 7 pa-
tients (4.0%) presented orogenito-cutaneous lesions. Six
patients (3.5%) had an isolated OLP, one (0.5%) suffered
from orogenital (vulvovaginal-gingival syndrom) muco-
sal involvement and none had anal lesions. Considering
location only, OLP was present in 71 patients (41.0%)
and genital appearance in 10 patients (5.8%) (Figure 4).
Nail involvement was noted in 11 patients (6.4%).
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TABLE 1
CLINICAL CHARACTERISTIC OF THE LICHEN PLANUS PATIENTS
Total (N=173) Males (N=65) Females (N=108) p
Age (mean±SE) 50±14 45.8±1.7 52.0±1.3 0.005














Pruritus 153 (88.4%) 55 (84.6%) 98 (90.7%) NS
Hospitalization 48 (27.7%) 22 (33.8%) 26 (24.1%) NS
p – statistically significant comparison between males and females, NS – not statistically significant, SE – standard error,
































Fig. 4. Body site involvement of lichen planus in 173 patients ac-
















Fig. 5. Stressful events prior to lichen planus appearance accord-



















Fig. 3. Distribution of lichen planus in 173 patients according to
age groups and sex. F – females, M – males.
In males, genital lesions were significantly more com-
mon than in females (p=0.005), while the latter pre-
sented significantly more generalized lesions (p=0.042)
(Figure 4).
No statistical differences between the sexes were found
comparing the appearance of cutaneous LP and OLP.
Squamous cell carcinoma was not found in any patient.
Forty-eight patients (27.7%) had been hospitalized be-
cause of generalized eruption. The hospitalized patients
were significantly younger than the outpatient ones (p=
0.043) and had a significantly larger skin involvement of
trunk (p=0.005), lower extremities (p=0.014) or the
whole body (p=0.005). There was no significant diffe-
rence concerning clinical classification (mucous, muco-
cutaneous, cutaneous group), pruritus, stressful event,
OLP and age groups between hospitalized and non hospi-
talized patients.
Pruritus was the main complaint reported in 153 pa-
tients (88.4%), 55 of whom (35.9%) were male and 98
(64.1%) were female. Other sporadic accompanying symp-
toms (pain, burning) were detected in only a small num-
ber of patients.
None of the patients reported dysphagia.
Data on possible stressful events prior to LP appear-
ance were found in 36 out of 137 (26.3%) patients inter-
viewed. Unfortunately, these answers were unavailable
for the remaining 36 patients. They were categorized ac-
cording to stress precursors into three groups. In 18
cases (50.0%) the underlying disease (breast cancer, pros-
tatic disease, depression, ulcerative colitis, respiratory
infection, measles, etc.) was the possible stress precursor,
in 10 patients (27.7%) job-related problems (retirement,
reorganisation at work, conflicted personal relationships
etc.) were noted and in eight patients (22.3%) stress
events within family (death, childbirth, wedding, divor-
ce, etc.) preceded the eruption of LP. Patients with stress
precursors more frequently suffered from cutaneous LP
(Figure 5), especially patients with LP on the trunk, com-
pared to patients with no stress predisposition. No such
difference was found for OLP. For genital LP the num-
bers were too small for further evaluation.
No significant difference was found among the three
LP clinical groups regarding their age (Figure 6), sex,
hospitalization and pruritus.
Familial LP was not observed.
Discussion
Several studies have shown geographical variations in
the prevalence of LP from 0.4% in the USA to 6.2% in
some African countries17,18. To the best of our knowledge,
this is the first study to evaluate a thorough localization
of LP in a cohort of patients in the Central Europe with
LP prevalence around 1% or less (the prevalence in
Slovenia is estimated below 1%) and associate it to some
chosen variables19–24. Previously some studies on OLP
patients and extraoral localization of LP from the USA
and China had been published25,26. However, our group of
patients involved dermatologic patients and the compari-
son with OLP patients remains to be discussed.
Among 173 patients included in the present study,
more females (62.4%) than males (37.6%) were involved
contrary to the previous studies from Egypt and India
where males were predominant27,28. However, our results
are in accordance with the study from Greece29 where
women with LP were affected in 58.4%. These data from
different geographic regions may indicate that some geo-
graphical factors like environmental, immunological and/
or epidemiological may play an important role in sex dis-
tribution of the disease although LP appears to affect fe-
males preferentially30.
The median age of female patients with LP was statis-
tically higher compared to the median age of male pa-
tients. These results are in accordance with the results of
previous studies, where the average age of female pa-
tients with LP was higher in comperison to the average
age of males with LP22, too. Our study revealed that the
average age of the majority of male patients was as much
as a decade lower than the average age of the majority of
female patients which is comparable to findings of other
European studies of LP patients31,32. However, the study
from India showed just the opposite result with the aver-
age age of all patients being lower and the maximum age
range frequency for males being even two decades lower
than that of females28.
The portion of isolated skin lesions in our patients
(56.7%) was the same as in Bhattacharya et al.28 trial
(58.2%, N=232). Interestingly enough, in Indian pa-
tients the isolated mucosal involvement (25%) and in-
volvement of the nails (15.1%) was much higher com-
pared to the Slovenian ones (4.1% for mucosa, 6.4% for
nails). The variations in assessment of LP mucosal in-
volvement might be due to personal dermatologist’s opi-
nion during clinical examination of the patient. In the
literature33 the reported average nail involvement was
10% showing that nail changes are most probably not
specific or pathognomonic for LP. However, the Greeks
report 0.6% whereas the Egyptians showed even 18.0% of
nail involvement in their LP patients27,29.
In the study presented from the Department of Der-
matology significantly fewer women had genital involve-
ment compared to men which is completely opposite to
the results of Eisen et al. reporting genital involvement
in 20–25% of women with OLP compared to 3.7% of
men25. However, some of our results are comparable to
the Indian and Egyptian studies which were focused on





















Fig. 6. The three clinical groups of lichen planus patients accord-
ing to age groups, N=173.
dermatologic patients27,28. In the Indian study similar re-
sults concerning OLP (41.8%) and genital (5.2%) involve-
ment with male predominance in the latter were sta-
ted28. A much higher genital involvement (24%) was re-
ported by Anbar et al. in the Egyptian LP patients27.
Vulvovaginal-gingival and peno-gingival syndromes34 re-
present typical LP variants that include lesions on two
completely separate body regions. Among the studied
population one patient with orogenital localization (vul-
vovaginal-gingival syndrome), two patients with cutane-
ous and genital lesions and seven with genital, oral and
cutaneous LP were found. These cases would have proba-
bly not been recognized unless a thorough uniform clini-
cal evaluation had been undertaken in all patients. We
agree with Moyal-Barracco et al.35 that the incidence of
genital LP is still underestimated because physicians do
not routinely examine the anogenitalia of their patients
with LP and, secondly, because genital lesions may be
asymptomatic or subclinical. However, a long-term fol-
low-up and biopsy of all non-healing ulcerative and papu-
lar lesions are recommended as the risk for developing
SCC may be increased36. Using strict diagnostic criteria
several studies have shown a significant risk of malig-
nant transformation of LP to SCC varying between 0.4 to
5.0%, most probably being independent of clinical type or
treatment used37.
Fortunately, none of our patients suffered from SCC.
Patients with oral LP should be examined for other
mucosal (genital and anal) lesions and in patients with
anogenital LP their oral cavity should be inspected38–40.
A multidisciplinary approach is often necessary to evalu-
ate the extent of the disease, since the cutaneous mani-
festation of LP may represent only the top of the iceberg.
Studies have demonstrated that one to two thirds30,34,41
of patients with cutaneous LP concomitantly present
oral lesions, one third of them being asymptomatic30.
Similar results were found in our study as 68 patients
(39.3%) had orocutaneous or orogenito-cutaneous lesions.
Since atrophic and erosive OLP could have a malignant
potential, a thorough oral examination, evaluation of the
disease and follow up are mandatory to detect carcino-
mas in the early stages or even prevent them42. Such pre-
ventive strategy is reliable only if clinical evaluation of
oral and anogenital region is routinely performed in all
patients with cutaneous LP, since mucosal manifesta-
tions usually persist further on despite spontaneous cu-
taneous remission.
Pruritus was a noteworthy symptom present in 88%
of our patients which is comparable to Bhattacharya et al.
results (79.3%) and much higher than reported by Egyp-
tians (50%)27,28.
Dickens et al. reported oesophageal LP in nearly one
third of patients with oral LP who had performed endos-
copy during the screening programme43. Since most of
the oesophageal LP appears to be asymptomatic this con-
dition remains unrecognized and underreported, which
was most probably the case in our study where no such
complaints were found in the group of studied patients.
However, one should be aware that chronic oesophageal
pain and oesophageal strictures had been previously
mentioned due to untreated oesophageal LP44. There-
fore, all patients with OLP should be questioned about
dysphagia and evaluated by endoscopy, if symptomatic30.
Since LP and OLP in particular are suggested to be
one of the psychosomatic diseases, the evaluation of the
psychological status should always be involved as a part
of a careful history examination45. Depression, anxiety
and increased stress level (divorce or spouse death) are
common in these patients46,47 and stress is known to be
one of the most frequent causes of acute exacerbations of
LP48. Various stress precursors of LP were found in
26.3% (36/137) of our studied patients. However, no con-
trol group was included in our study to evaluate the data
on stressful events. A much smaller portion of patients
(5.2%) was aware of a precipitant stressful incident be-
fore the onset of disease in the Indian study28. However,
in the same study chronic anxiety had been reported as
an aggravating factor of LP in 20.3% of Indian patients.
The involvement of a psychologist has been suggested in
order to optimize the investigation and treatment in a se-
vere disease with symptoms and complications affecting
the patient’s quality of life47.
Since patients with LP vary greatly in severity of
symptoms, extent of lesion involvement, their location,
as well as psychological vulnerability and exposure to
stressful events beside individualized therapy, the pa-
tient education on LP should represent an important
part of a treatment process. We should reassure patients
that LP is not contagious and that the natural course of
the disease may last on the average for as long as one to
two years, yet symptomatic treatment often relieves itch-
ing and improves the appearance. Avoiding skin injuries
(scratching, accidents, sunlight) should be encouraged
since new lesions may form in damaged skin. As stress
and mental disturbance could contribute to LP appear-
ance and reappearance, patients should avoid conflicting
situations as much as possible and psychologist counsel-
ling may be beneficial along with the conventional the-
rapy49. We believe that patient education, treatment, as
well as emotional support could provide improvement in
patients’ quality of life.
Although thorough examination and treatment of
skin and mucous LP lesions are expected to be the com-
petence of dermatologists, other medical specialists such
as family physicians, dentists, gynaecologists, proctolo-
gists, paediatricians, etc. are more or less faced with LP
patients at their routine work. It is highly advisable that
they should all be involved in complete management of
the latter. Our study clearly suggests that they should
perform or assure a thorough examination of the skin in-
cluding oral, genital and anal mucosa in each patient
with LP to avoid a delay in diagnosis and proper treat-
ment and even to possibly disclose a much more serious
underlying condition such as disorders of autoimmune
origin (myasthenia gravis, ulcerative colitis, coeliac dis-
ease) and eventual HCV infection6,50,51. Besides, psycho-
logical support should be offered, in case the patient’s
thorough history implicates the need for it.
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KORISNOST TEMELJITE KLINI^KE EVALUACIJE KO@E TE ORALNE, GENITALNE I
ANALANE SLUZNICE KOD PACIJENATA S DIJAGNOZOM LICHEN PLANUSA
S A @ E T A K
Lichen planus (LP) uobi~ajena je sluzoko`na bolest nepoznate etiologije s razli~itom geografskom prevalencijom, a
mo`e biti povezana s nekim ozbiljnim poreme}ajima poput skvamoznog karcionoma stanice i obi~no ostaje nedijagno-
sticirana. Cilj ove studije bio je temeljito determinirati lokalizaciju i klini~ke karakteristike LP lezija na 173 slovenska
pacijenta u asocijaciji s prisutno{}u prate}ih simptoma i povijesti potencijalno stresnih doga|aja. Izolirane ko`ne lezije
LP-a prona|ene su u 56,6%, a izolirani oralni LP u 3,5% pacijenata. Prisutnos LP na usnoj sluznici je 34%, dok je
prisutnost LP na sluznici genitalija zabilje`ena u 1,2%, na orogenitalnoj ko`i u 4% i orogenitalni LP u 1,5% pacijenata.
Inherentni stresni doga|aj zabilje`en je kod 36 od 137 (26,3%) pacijenata. Unato~ o~itoj vidljivosti lezija doktori medi-
cine trebali bi biti upoznati s LP-om te temeljito pregledati ko`u, jednako kao i oralnu, genitalnu i analnu sluznicu kod
svakog LP pacijenta kako bi se izbjegla zaka{njela dijagnoza bolesti i mogu}e priop}avanje o te{kom temeljnom stanju.
Psiholo{ka podr{ka trebala bi tako|er biti ponu|ena ako je potrebna.
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